pI: 8.6317 |
Length (AA): 310 |
MW (Da): 33969 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
7 | 294 | 2lck (A) | 15 | 300 | 29.00 | 0 | 0.21 | 0.894832 | 1.98 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_129029)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G33820 | mitochondrial ornithine transporter |
Brugia malayi | Bm1_17435 | Mitochondrial carrier protein |
Candida albicans | CaO19.5926 | potential mitochondrial carrier protein similar to S. cerevisiae ORT1 (YOR130C) ornithine transporter |
Candida albicans | CaO19.13347 | potential mitochondrial carrier protein similar to S. cerevisiae ORT1 (YOR130C) ornithine transporter |
Caenorhabditis elegans | CELE_T10F2.2 | Protein T10F2.2 |
Drosophila melanogaster | Dmel_CG1628 | CG1628 gene product from transcript CG1628-RC |
Homo sapiens | ENSG00000120329 | solute carrier family 25 (mitochondrial carrier |
Homo sapiens | 10166 | solute carrier family 25 (mitochondrial carrier |
Leishmania braziliensis | LbrM.25.0210 | mitochondrial carrier protein, putative |
Leishmania donovani | LdBPK_250210.1 | mitochondrial carrier protein, putative |
Leishmania infantum | LinJ.25.0210 | mitochondrial carrier protein, putative |
Leishmania major | LmjF.25.0210 | mitochondrial carrier protein, putative |
Leishmania mexicana | LmxM.25.0210 | mitochondrial carrier protein, putative |
Loa Loa (eye worm) | LOAG_04855 | carrier protein |
Mus musculus | ENSMUSG00000031482 | solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15 |
Oryza sativa | 9267032 | Os11g0423800 |
Saccharomyces cerevisiae | YOR130C | Ort1p |
Schistosoma japonicum | Sjp_0202340 | Mitochondrial ornithine transporter 1, putative |
Schistosoma mansoni | Smp_000680 | ornithine transporter 2 (solute carrier family 25 member 2) |
Schmidtea mediterranea | mk4.001170.03 | Ornithine transporter 2 |
Trypanosoma brucei gambiense | Tbg972.11.150 | mitochondrial carrier protein, putative |
Trypanosoma brucei | Tb927.11.270 | mitochondrial carrier protein |
Trypanosoma congolense | TcIL3000.11.180 | mitochondrial carrier protein, putative |
Trypanosoma cruzi | TcCLB.504109.70 | mitochondrial carrier protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.03.0870 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.03.0870 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.03.0870 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.03.0870 this record | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.5
1 literature reference was collected for this gene.